centuri
one
greatest
challeng
public
health
clinic
microbiologist
rapid
detect
identif
emerg
reemerg
pathogen
complex
factor
genet
variat
host
pathogen
environment
chang
popul
pressur
global
travel
influenc
emerg
infecti
diseas
sar
epidem
highlight
potenti
emerg
pathogen
spread
global
short
time
frame
peruski
peruski
diagnost
infecti
diseas
greatli
affect
past
year
longer
cultiv
microscopi
mean
detect
infecti
agent
introduct
molecular
diagnost
abil
detect
minut
amount
microbi
nucleic
acid
clinic
specimen
revolution
clinic
microbiolog
particular
util
pcr
allow
detect
quantit
specif
agent
matter
hour
pcr
sequenc
specif
segment
nucleic
acid
allow
determin
specif
drug
resist
aid
guid
viral
therapi
german
physician
name
robert
koch
race
discov
caus
agent
diseas
destroy
cattl
sheep
europ
koch
found
rodshap
bacteria
blood
dead
cattl
known
today
bacillu
anthraci
abl
cultur
bacteria
nutrient
inject
cultur
bacteria
back
healthi
anim
healthi
anim
feel
ill
die
koch
abl
isol
bacteria
blood
dead
anim
perform
seri
experi
koch
abl
demonstr
infecti
diseas
anthrax
caus
specif
infecti
agent
b
anthraci
techniqu
use
demonstr
mycobacterium
tuberculosi
caus
agent
tuberculosi
thu
koch
seri
experi
known
today
koch
postul
provid
foundat
studi
etiolog
infecti
diseas
although
koch
postul
use
determin
caus
mani
bacteri
infect
time
principl
appli
exampl
organ
uncultiv
artifici
medium
also
situat
number
differ
pathogen
caus
similar
clinic
symptom
singl
pathogen
caus
sever
patholog
applic
molecular
diagnost
use
overcom
situat
techniqu
allow
rapid
detect
fastidi
uncultiv
unknown
agent
use
univers
primer
multiplex
system
panel
organ
target
use
screen
clinic
specimen
molecular
method
wide
use
tool
epidemiolog
fingerprint
isol
import
public
health
use
sequencebas
identif
strain
type
specif
marker
comprehens
isol
fingerprint
use
track
control
diseas
scientist
institut
genom
research
tigr
unveil
first
two
complet
dna
sequenc
bacteri
genom
haemophilu
influenza
mycoplasma
genitalium
follow
first
complet
genom
sequenc
archaea
methanococcu
jannaschii
scientif
achiev
made
possibl
use
autom
sequenc
equip
sinc
tigr
other
complet
genom
sequenc
mani
pathogen
well
number
microorgan
environment
relev
comparison
genom
pinpoint
differ
virul
avirul
medic
import
pathogen
speci
level
genom
comparison
provid
inform
host
tissu
specif
evolutionari
level
comparison
genom
help
reveal
origin
microbi
life
doolittl
viral
genom
smaller
mutat
faster
bacteri
genom
current
technolog
alreadi
tap
use
viral
genom
guid
drug
therapi
implement
viral
load
test
specif
nucleic
acid
sequenc
provid
physician
valuabl
inform
regard
clinic
respons
patient
antivir
therapi
emerg
antivir
drug
resist
smith
et
al
foundat
studi
biolog
process
protein
level
driven
rapid
progress
genom
identif
character
protein
express
cell
microbi
host
differ
cellular
state
grow
area
interest
messeng
rna
often
splice
differ
way
code
differ
protein
simpli
know
gene
sequenc
transcript
express
enough
understand
critic
protein
function
studi
proteom
next
frontier
understand
genom
function
goal
proteom
defin
character
complet
set
protein
proteom
organ
tissu
cell
determin
spatial
tempor
variat
increasingli
appli
studi
variou
microbi
process
eg
host
pathogen
interact
proteom
hold
great
promis
enhanc
knowledg
cell
function
variou
condit
thu
may
allow
breakthrough
new
gener
diagnost
antimicrobi
agent
vaccin
candid
though
situ
hybrid
ish
typic
perform
histolog
rather
clinic
microbiolog
laboratori
provid
extrem
use
inform
clinic
microbiologist
sever
pathogen
target
use
direct
hybrid
nucleic
acid
probe
situ
bacteri
target
includ
helicobact
pylori
makristathi
et
al
legionella
spp
hayden
et
al
yeast
form
dimorph
fungi
hayden
et
al
mold
aspergillu
spp
fusarium
spp
pseudoallesheria
spp
hayden
et
al
hayden
et
al
also
proven
use
ish
target
typic
situ
hybrid
chosen
use
pathogen
identifi
associ
intact
cell
tissu
branch
dna
probe
use
identifi
presenc
human
papilloma
viru
hpv
gene
express
signal
hpv
mrna
kenni
et
al
method
cultur
confirm
pna
fish
peptid
nucleic
acid
fluoresc
situ
hybrid
use
identifi
staphylococcu
aureu
stender
coagulaseneg
staphylococci
posit
blood
cultur
advandx
woburn
usa
although
situ
techniqu
hybrid
protect
assay
use
rrna
probe
matrix
use
rapid
identif
bacteria
fungi
routin
blood
cultur
marlow
et
al
studi
enterobacteriacea
pseudomona
aeruginosa
gramneg
bacteria
staphylococcu
aureu
coagulaseneg
staphylococci
streptococci
enterococci
gramposit
bacteria
anaerob
yeast
success
identifi
use
hybrid
method
prove
sensit
specif
effici
extract
prepar
specimen
nucleic
acid
analysi
critic
qualiti
molecular
test
result
past
decad
improv
novel
conveni
extract
scheme
allow
routin
integr
molecular
test
mani
clinic
diagnost
laboratori
recent
evolut
extract
system
autom
format
allow
common
practic
molecular
test
sever
review
serv
refer
specif
detail
extract
chemistri
realtim
instrument
wolk
et
al
wolk
pers
specimen
prepar
autom
divid
three
categori
nucleic
acid
extract
ii
specimen
processingpcr
assay
setup
iii
gener
liquid
hand
system
system
combin
part
categori
one
system
tabl
mani
compani
develop
autom
system
integr
realtim
pcr
instrument
complet
autom
extract
sampl
process
amplificationdetect
qiagen
qiagen
valencia
ca
usa
six
differ
robot
system
clinic
research
applic
extract
nucleic
acid
varieti
specimen
robot
system
avail
addit
research
applic
autom
extract
system
use
varieti
pcr
realtim
pcr
instrument
nucleic
acid
detect
system
offer
clinic
use
design
accommod
laboratori
depend
specimen
volum
need
biorobot
workstat
purifi
nucleic
acid
sampl
use
prefil
dna
rna
kit
avail
card
biorobot
process
sampl
per
run
respect
two
system
use
magattract
magnet
particl
technolog
dna
extract
ultraviolet
light
decontamin
surfac
run
biorobot
mdx
workstat
process
sampl
equip
vacuum
process
elimin
need
centrifug
present
earlier
biorobot
mdx
system
use
bar
code
specimen
track
highthroughput
test
optim
biorobot
equip
run
qiamp
protocol
extract
dna
rna
barcod
specimen
track
qiagen
biorobot
evalu
dna
rna
virus
extract
effici
found
equival
manual
method
espi
et
al
knepp
et
al
forman
valsamaki
xu
et
al
roch
roch
molecular
biochem
indianapoli
usa
three
autom
instrument
magna
lyser
instrument
autom
tissu
homogen
unit
combin
autom
nucleic
acid
extractor
nucleic
acid
magna
pure
compact
magna
pure
lc
magna
pure
compact
small
footprint
extract
nucleic
acid
sampl
use
differ
compact
nucleic
acid
kit
small
larg
volum
magna
pure
lc
process
sampl
h
lc
model
autom
extract
pcr
setup
lightcycl
capillari
coba
are
plate
tube
magna
pure
lc
evalu
bacteria
parasit
fungi
dna
virus
rna
virus
found
equival
manual
method
espi
et
al
loeffler
et
al
germer
et
al
holzl
et
al
knepp
et
al
leb
et
al
lee
et
al
cook
et
al
dalesio
et
al
muller
et
al
tang
et
al
coba
ampliprep
autom
system
coba
amplicor
analyz
avail
unit
state
except
research
purpos
coba
ampliprep
report
literatur
suitabl
routin
test
decreas
handson
time
gartner
et
al
stelzl
et
al
nextgener
coba
coba
taqman
avail
capac
run
two
differ
assay
individu
pcr
profil
lightcycl
system
also
avail
allow
channel
detect
instead
previou
channel
detect
biomerieux
biomerieux
marci
letoil
franc
three
system
nucleic
acid
extract
nuclisen
extractor
use
silica
dioxid
boom
extract
protocol
boom
et
al
nuclisen
easymag
nuclisen
minimag
use
magnet
silica
nuclisen
extractor
autom
close
system
compar
qiagen
manual
extract
found
effici
extract
viral
dna
rna
gobber
et
al
easymag
autom
magnet
silica
extract
system
extract
sampl
less
hour
minimag
manual
system
extract
sampl
min
offer
lowcost
extract
system
smaller
molecular
laboratori
recent
studi
suggest
minimag
consist
provid
high
yield
low
titer
target
tang
et
al
system
design
extract
dna
rna
use
either
nucleic
acid
sequencebas
identif
nasba
pcr
amplif
technolog
nuclisen
easi
q
also
coupl
extract
method
detect
realtim
nasba
minimag
use
easyq
realtim
nasba
hiv
assay
accur
quantifi
hiv
sixlog
rang
appli
biosystem
abi
foster
citi
ca
usa
two
nucleic
acid
extract
system
use
proprietari
flowthrough
chemistri
abi
prism
nucleic
acid
prep
station
program
defin
extract
protocol
abi
prism
autom
nucleic
acid
workstat
fulli
autom
system
extract
nucleic
acid
prepar
pcr
reaction
initi
revers
transcript
step
rtpcr
sampl
abi
prism
use
autom
largescal
surveil
west
nile
viru
outbreak
northeastern
unit
state
shi
et
al
workstat
interfac
exist
abi
pcr
instrument
abi
prism
geneamp
corbett
research
distribut
phenix
research
product
hayward
ca
usa
offer
two
separ
autom
instrument
xtractor
gene
rnadna
extract
liquid
handl
system
setup
standard
realtim
pcr
reaction
configur
support
plate
rotorgen
well
rotor
use
rotorgen
fourchannel
realtim
pcr
fluoresc
detector
becton
dickinson
bd
franklin
lake
nj
usa
autom
sampl
processor
bdprobetec
et
system
bd
viper
sampl
processor
design
autom
sampl
process
highvolum
test
neisseria
gonorrhoea
chlamydia
trachomati
shift
genprob
genprob
incorpor
san
diego
ca
usa
launch
tigri
fulli
autom
instrument
highvolum
test
shift
tigri
incorpor
genprob
target
captur
technolog
sampl
process
transcriptionmedi
amplif
tma
amplif
hybrid
protect
assay
hpa
detect
one
instrument
current
tigri
limit
use
genprob
aptima
n
gonorrhoeaec
trachomati
assay
procleix
hivhcv
blood
screen
assay
genprob
also
offer
dt
system
manufactur
tecan
research
triangl
park
nc
usa
autom
liquid
handl
variou
diagnost
kit
abbott
abbott
laboratori
abbott
park
il
usa
develop
autom
sampl
prepar
workstat
design
process
sampl
h
use
magnet
microparticlebas
protocol
report
abbott
integr
abi
prism
detect
system
beckman
coulter
hamilton
tecan
offer
robot
liquid
handl
system
offer
flexibl
molecular
diagnost
lab
beckman
coulter
fullerton
ca
usa
avail
sever
liquid
handl
system
use
extract
nucleic
acid
set
pcr
sequenc
reaction
well
immunodetect
assay
system
includ
biomek
nx
biomek
fx
biomek
biomek
hamilton
microlab
star
let
hamilton
compani
reno
nv
usa
benchtop
workstat
assay
autom
use
nucleic
acid
extract
pcr
setup
vector
softwar
variou
accessori
allow
user
custom
protocol
laboratori
need
tecan
support
freedom
evo
pcr
workstat
also
offer
flexibl
softwar
accessori
allow
user
custom
protocol
need
cepheid
biorad
stratagen
offer
realtim
pcr
system
could
combin
mani
autom
system
cepheid
smartcycl
cepheid
sunnyval
ca
usa
offer
flexibl
realtim
pcr
detect
allow
multipl
low
sampl
number
test
perform
simultan
independ
programm
reaction
cell
higher
throughput
cepheid
announc
plan
launch
genexpert
system
would
realtim
system
integr
sampl
prepar
amplif
detect
singleus
cartridg
contain
lyophil
reagent
biorad
hercul
ca
usa
offer
realtim
detector
icycl
multiplex
five
fluorophor
addit
offer
miniopticon
twocolor
system
opticon
ii
twocolor
system
fourcolor
system
formerli
mj
research
stratagen
stratagen
san
diego
ca
usa
system
includ
although
mani
advanc
autom
nucleic
acid
extract
sampl
process
amplif
studi
compar
variou
autom
system
limit
studi
avail
demonstr
autom
system
compar
well
manual
method
espi
et
al
knepp
et
al
autom
limit
risk
contamin
decreas
handson
time
reduc
repetitivemot
disord
among
technician
ultim
decis
implement
autom
molecular
lab
depend
cost
specimentest
volum
laboratori
workflow
use
molecular
techniqu
epidemiolog
studi
import
rapid
focus
diseas
detect
implement
infect
control
measur
molecular
type
becom
valuabl
tool
defin
diseas
sourc
determin
transmiss
modal
track
outbreak
diekema
et
al
soll
et
al
pulsefield
gel
electrophoresi
pgfe
consid
refer
method
compar
purpos
although
variou
method
use
tenov
et
al
oliv
bean
goer
weller
although
pgfe
consid
reliabl
discriminatori
reproduc
method
expens
time
consum
make
techniqu
difficult
hospit
use
routin
form
support
infectioncontrol
practition
outbreak
investig
weller
shopsin
kreiswirth
stranden
et
al
due
test
condit
inher
geltogel
variabl
pgfe
make
difficult
compar
interinstitut
electrophoresi
result
public
health
laboratori
standard
pfge
use
outbreak
investig
digit
imag
provid
standard
crossgel
compar
properti
still
techniqu
rel
cumbersom
practic
hospit
laboratori
recent
cdc
jcaho
recommend
use
molecular
test
gold
standard
investig
hospitalacquir
infect
hospit
face
difficult
choic
refer
specimen
refer
laboratori
state
public
health
laboratori
test
invest
hospitalbas
infrastructur
support
genotyp
current
gap
abil
provid
result
molecular
epidemiolog
hand
clinic
microbiologist
infectioncontrol
practition
though
numer
bacteri
genotyp
method
emerg
use
outbreak
investig
molecular
epidemiolog
complet
standard
practic
among
pcrbase
amplif
subsequ
type
rademak
savelkoul
genotyp
via
variabl
number
tandem
repeat
vntr
mathema
kreiswirth
multilocu
sequenc
type
mlst
hanag
et
al
autom
ribotyp
pfaller
holli
provid
option
although
use
tool
vari
strength
limit
goer
two
method
appear
promis
translat
routin
clinic
laboratori
practic
reppcr
ribotyp
repetitiveel
sequencebas
pcr
reppcr
dna
fingerprint
method
success
use
rapid
molecular
tool
outbreak
investig
oxacillin
resist
aureu
orsa
versalov
et
al
del
vecchio
et
al
van
der
zee
et
al
deplano
et
al
success
demonstr
discriminatori
type
organ
salmonella
typhi
escherichia
coli
bacillu
speci
oliv
bean
reppcr
method
exploit
presenc
repetit
element
dispers
throughout
chromosom
orsa
organ
repetit
element
differ
specif
posit
within
genom
among
differ
strain
microorgan
primer
design
amplifi
genet
region
repetit
element
allow
gener
pcr
amplif
product
variou
size
wood
et
al
electrophoresi
differ
size
product
deriv
differ
organ
strain
produc
uniqu
gelband
pattern
fingerprint
strain
compar
differenti
recent
advanc
improv
commerci
reppcr
fragment
analysi
use
capillari
electrophoresi
bacteri
bar
code
inc
atlanta
ca
usa
enabl
standard
reproduc
perform
reppcr
may
provid
promis
option
rapid
costeffect
outbreak
investig
hospit
commun
rapid
accur
determin
drug
suscept
clinic
isol
use
variou
aspect
patient
therapi
presenc
resist
marker
also
help
distinguish
ambigu
break
point
associ
suscept
test
wellcharacter
resist
gene
use
monitor
epidemiolog
spread
commun
hospit
despit
fact
still
remain
much
learn
marker
applic
molecular
diagnost
method
detect
drug
resist
evolv
routin
practic
laboratori
use
molecular
method
detect
resist
appli
bacteria
virus
fungi
advantag
use
molecular
test
reli
timeconsum
incub
mediadepend
express
thu
educ
choic
therapi
initi
earli
diagnosi
impact
patient
outcom
particularli
slowgrow
organ
mycobacterium
spp
inderleid
pfyffer
antimicrobi
resist
gene
among
bacteria
includ
resist
aminocylitol
aminoglycosid
chloramphenicol
fluoroquinolon
glycopeptid
isoniazid
macrolid
mupicurin
rifampin
sulfonamid
tetracyclin
trimethaprim
fluit
et
al
rashe
tenov
tenov
rashe
list
pcr
primer
use
target
resist
marker
see
tenov
rashe
perhap
welldocu
appli
use
marker
bacteria
oxacillinresist
staphylococcu
aureu
orsa
formerli
mrsa
vancomycinresist
enterococcu
vre
meca
gene
mediat
oxacillin
resist
orsa
vana
vanb
gene
primarili
mediat
acquir
vancomycin
resist
vre
commerci
avail
test
orsa
includ
latex
agglutin
test
product
meca
cycl
probe
technolog
pcr
detect
meca
aureu
pcr
use
detect
track
orsa
vre
clark
et
gordt
et
al
aarestrup
et
al
satak
et
al
hussain
et
al
padiglion
et
al
grisold
et
al
jona
et
al
louie
et
al
mae
et
al
francoi
et
al
strommeng
et
al
sloan
et
al
review
diekema
et
al
highlight
fact
togeth
orsa
vre
two
import
resist
pathogen
us
hospit
rapid
detect
remain
need
antimicrobi
resist
continu
increas
worldwid
activ
surveil
proper
isol
infect
patient
use
rapid
pcr
technolog
could
play
import
role
identifi
carrier
upon
hospit
admiss
aid
prevent
control
effort
orsa
vre
routin
use
test
would
sensit
specif
would
also
cost
effect
proven
infect
prevent
studi
detect
viral
mutat
associ
drug
resist
well
document
exampl
includ
polymeras
proteas
inhibitor
human
immunodefici
viru
hiv
acyclovir
penciclovir
resist
herp
simplex
viru
acyclovir
resist
varicellazost
viru
ganciclovir
resist
cytomegaloviru
famciclovir
lamivudun
resist
hepat
b
viru
amantidin
resist
influenza
shafer
chou
viral
mutat
commonli
detect
direct
sequenc
specif
viral
read
frame
encod
protein
target
current
avail
antivir
drug
genotyp
resist
test
mang
patient
wide
use
physician
current
two
commerci
avail
fdaclear
sequenc
assay
includ
reagent
kit
softwar
two
kit
truegen
genotyp
kit
opengen
dnasequenc
system
bayer
corp
tarrytown
ny
usa
viroseq
genotyp
system
appli
biosystem
foster
citi
ca
usa
genotyp
test
requir
skill
laboratori
profici
sequenc
align
edit
mutat
detect
interpret
sequenc
commerci
avail
line
probe
assay
lipa
revers
hybrid
method
allow
laboratori
profici
pcr
limit
sequenc
capabl
detect
mutat
without
need
sequenc
descamp
et
al
schmit
et
al
comparison
studi
viral
genotyp
method
prove
reliabl
accur
howev
lipa
design
identifi
known
primari
mutat
associ
highlevel
drug
resist
direct
sequenc
detect
new
mutat
erali
et
al
hanna
daquila
grant
et
al
caliendo
yenlieberman
rapid
detect
antifung
resist
use
primarili
due
increas
fungal
infect
among
immunocompromis
patient
current
antifung
assay
reli
fungal
suscept
test
depend
growth
practic
applic
antifung
molecular
test
yet
seen
still
much
learn
genet
marker
mediat
resist
genet
inform
need
examin
fungal
resist
molecular
level
much
complex
virus
could
involv
evalu
fungal
gene
express
review
molecular
mechan
antifung
resist
see
edlind
full
potenti
molecular
diagnost
drugresist
test
microbiolog
reach
applic
still
infanc
molecular
mechan
antimicrobi
resist
describ
newer
technolog
enhanc
util
marker
test
microarray
technolog
promis
impact
rapid
accur
detect
multipl
mutat
associ
resist
bacteria
mycobacteria
virus
fungi
molecular
diagnost
laboratori
perform
molecular
resist
test
need
ensur
qualiti
control
specimen
current
still
need
cultiv
organ
test
antimicrobi
type
epidemiolog
studi
thu
import
retain
specimen
inocul
cultur
laboratori
sure
result
neg
specimen
discard
diekema
et
al
full
potenti
drugresist
marker
understood
rapid
molecular
antimicrobi
test
must
still
combin
tradit
microbi
cultiv
though
infanc
proteom
technolog
potenti
play
key
role
futur
clinic
microbiolog
diagnost
techniqu
becom
rapid
afford
list
applic
biomark
expand
mass
spectroscopi
ms
gel
electrophoresi
common
techniqu
microbi
proteom
dougla
gel
electrophoresi
protein
first
separ
isoelectr
point
pi
glass
tube
bjellqvist
et
al
gel
remov
glass
place
horizont
top
polyacrylamid
slab
gel
polyacrylamid
gel
electrophoresi
page
separ
protein
similar
charg
size
molecular
weight
gel
electrophoresi
simpl
method
catalogu
microbi
protein
grown
differ
condit
diseas
state
mass
spectromet
take
protein
page
separ
produc
charg
particl
ion
shevchenko
et
al
mass
spectromet
differenti
move
ioniz
molecul
separ
masstocharg
mz
ratio
vacuum
mean
electromagnet
field
sake
discuss
one
assum
compon
mixtur
differ
molecular
weight
mass
spectrum
contain
uniqu
peak
compound
present
inform
differ
type
mass
spectroscopi
refer
dougla
report
begun
surfac
clinic
microbiolog
literatur
describ
proteom
method
may
impact
laboratori
futur
one
report
matrixassist
laser
desorptionion
timeofflight
mass
spectroscopi
malditofm
use
rapidli
identifi
fungal
protein
evok
specif
human
immun
respons
may
prove
link
activ
infect
outcom
pitarch
et
al
anoth
studi
malditofm
gelelectrophoresi
tandem
mass
spectrometri
use
identifi
intraamniot
protein
could
lead
discoveri
novel
human
biomark
human
intraamniot
infect
gravett
et
al
ultim
tool
help
elucid
interact
protein
protein
precursor
dna
mrna
add
understand
pathogenesi
diseas
understand
novel
biomark
earli
detect
diseas
diseas
outcom
expect
occur
one
emerg
technolog
luminex
xmap
system
identifi
multipl
immun
protein
like
serotypespecif
antibodi
singl
well
tube
multiplex
format
use
identifi
multipl
immun
protein
jone
et
al
bacteri
dna
dunbar
et
al
routin
applic
clinic
laboratori
requir
translat
although
mass
spectrometri
typic
use
identifi
protein
highperform
mass
spectrometri
recent
adapt
develop
use
conjunct
pcr
rapid
identif
strain
type
emerg
pathogen
bacillu
anthraci
coronaviru
among
other
van
ert
et
al
ecker
et
al
sampath
et
al
conclus
past
year
molecular
method
emerg
essenti
tool
clinic
microbiolog
workplac
identif
bacteri
viral
fungal
parasit
genom
drive
emerg
new
technolog
identifi
pathogen
rapidli
limit
singl
target
approach
still
exist
miniatur
robot
autom
allow
even
small
health
care
facil
implement
molecular
method
new
discoveri
human
genom
link
diseas
suscept
infect
human
mutat
antibiot
util
certainli
continu
impact
clinic
laboratori
next
year
broaden
scope
clinic
microbiolog
detect
includ
predict
via
protein
nucleic
acid
target
final
miniatur
techniqu
mass
spectroscopi
pcr
amplicon
could
chang
entir
face
clinic
microbiolog
multipl
pathogen
could
amplifi
simultan
detect
genotyp
allow
rapid
detect
mani
emerg
pathogen
infect
